PRIMECAP Management's position in Abbott Laboratories is currently worth $97.5 Million. That's 0.07% of their equity portfolio (134th largest holding). The first Abbott Laboratories trade was made in Q1 2013. Since then PRIMECAP Management bought shares eight more times and sold shares on 36 occasions. The stake costed the investor $32.8 Million, netting the investor a gain of 197% so far.
Smithbridge Asset Management Inc. DE grew its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 1.1% in the third quarter, according to its ...
The AM Reporter, 5 months ago… at approximately $28,000. Financial Gravity Asset Management Inc. … during the first quarter. Financial Gravity Asset Management Inc. … the last quarter. H...
EIN News Finance, 6 months ago… Analysis on ABT About Abbott Laboratories (Free Report) Abbott Laboratories , together with its … in four segments: Established Pharmaceutical Products, Di...
EIN News Pharmaceuticals, 6 months agoHB Wealth Management LLC raised its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 7.6% in the third quarter, according to its most re...
The AM Reporter, 6 months ago